A diabetic retinopathy screening program as a strategy for blindness prevention. 1997

C González Villalpando, and M E González Villalpando, and S Martínez Díaz, and D Rivera Martínez, and B Arredondo Pérez, and S Islas Andrade, and M P Stern
Centro de Estudios en Diabetes, American British Cowdray Hospital, Mexico D.F. cgonzala@buzon.main.conacyt.mx

The most frequent cause of preventable blindness in adults, in the developed world, is diabetic retinopathy (DR). The early treatable phase of this complication is clinically silent. In order to institute effective laser photocoagulation and prevention of blindness, timely detection is crucial. Consequently there is a need for periodic funduscopic examinations of all diabetics. Due to the high prevalence of DM in Mexico most of the primary care facilities are limited. We present the results of a DR screening program (DRSP) using a mobile unit equipped with a fundus photography camera, parked outside of a clinic. We report the prevalence of the various stages of DR and clinical characteristics observed in this population as well as our experience working in such an environment. The study period was from September 1 to December 22, 1995. All the diabetics that presented for care to the clinic were identified and all other persons were invited to participate. A total of 231 participants were invited (112 men, 119 women). Non-stereo fundus photos of two retinal fields (macula and optic disk centered) were taken with technique and classification according to international standards. Response rate to the invitation was 95.3%. Mean age was 62.4 +/- 13 years and 63.5 +/- 10 years and duration of diabetes was 12.3 +/- 10.1 years and 11.0 +/- 7.5 years for men and women, respectively. DR was detected in 38% of the cases, of these only 5.6% have received treatment. DR was uncovered in 84.5% of the cases and was associated with duration of diabetes (p < 0.001 in men and p = 0.04 in women) and hyperglycemia (in men p < 0.005, only). DR has a high prevalence in this population and can be detected through a screening program which reveals undiagnosed high risk DR in an efficient, and standardized manner.

UI MeSH Term Description Entries
D006949 Hyperlipidemias Conditions with excess LIPIDS in the blood. Hyperlipemia,Hyperlipidemia,Lipemia,Lipidemia,Hyperlipemias,Lipemias,Lipidemias
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D008403 Mass Screening Organized periodic procedures performed on large groups of people for the purpose of detecting disease. Screening,Mass Screenings,Screening, Mass,Screenings,Screenings, Mass
D008800 Mexico A country in NORTH AMERICA, bordering the Caribbean Sea and the Gulf of Mexico, between BELIZE and the UNITED STATES, and bordering the North Pacific Ocean, between Guatemala and the UNITED STATES.
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008952 Mobile Health Units Movable or portable facilities in which diagnostic and therapeutic services are provided to the community. Field Hospitals,Mobile Clinics,Mobile Health Vans,Mobile Hospitals,Clinic, Mobile,Clinics, Mobile,Field Hospital,Health Unit, Mobile,Health Units, Mobile,Health Van, Mobile,Health Vans, Mobile,Hospital, Field,Hospital, Mobile,Hospitals, Field,Hospitals, Mobile,Mobile Clinic,Mobile Health Unit,Mobile Health Van,Mobile Hospital,Unit, Mobile Health,Units, Mobile Health,Van, Mobile Health,Vans, Mobile Health
D011795 Surveys and Questionnaires Collections of data obtained from voluntary subjects. The information usually takes the form of answers to questions, or suggestions. Community Survey,Nonrespondent,Questionnaire,Questionnaires,Respondent,Survey,Survey Method,Survey Methods,Surveys,Baseline Survey,Community Surveys,Methodology, Survey,Nonrespondents,Questionnaire Design,Randomized Response Technique,Repeated Rounds of Survey,Respondents,Survey Methodology,Baseline Surveys,Design, Questionnaire,Designs, Questionnaire,Methods, Survey,Questionnaire Designs,Questionnaires and Surveys,Randomized Response Techniques,Response Technique, Randomized,Response Techniques, Randomized,Survey, Baseline,Survey, Community,Surveys, Baseline,Surveys, Community,Techniques, Randomized Response
D001766 Blindness The inability to see or the loss or absence of perception of visual stimuli. This condition may be the result of EYE DISEASES; OPTIC NERVE DISEASES; OPTIC CHIASM diseases; or BRAIN DISEASES affecting the VISUAL PATHWAYS or OCCIPITAL LOBE. Amaurosis,Bilateral Blindness,Blindness, Bilateral,Blindness, Legal,Blindness, Monocular,Blindness, Unilateral,Sudden Visual Loss,Unilateral Blindness,Blindness, Acquired,Blindness, Complete,Blindness, Hysterical,Blindness, Transient,Acquired Blindness,Amauroses,Bilateral Blindnesses,Complete Blindness,Hysterical Blindness,Legal Blindness,Monocular Blindness,Sudden Visual Losses,Transient Blindness,Visual Loss, Sudden
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood

Related Publications

C González Villalpando, and M E González Villalpando, and S Martínez Díaz, and D Rivera Martínez, and B Arredondo Pérez, and S Islas Andrade, and M P Stern
December 1989, BMJ (Clinical research ed.),
C González Villalpando, and M E González Villalpando, and S Martínez Díaz, and D Rivera Martínez, and B Arredondo Pérez, and S Islas Andrade, and M P Stern
November 1989, BMJ (Clinical research ed.),
C González Villalpando, and M E González Villalpando, and S Martínez Díaz, and D Rivera Martínez, and B Arredondo Pérez, and S Islas Andrade, and M P Stern
January 1997, Acta ophthalmologica Scandinavica. Supplement,
C González Villalpando, and M E González Villalpando, and S Martínez Díaz, and D Rivera Martínez, and B Arredondo Pérez, and S Islas Andrade, and M P Stern
March 1984, Diabetologia,
C González Villalpando, and M E González Villalpando, and S Martínez Díaz, and D Rivera Martínez, and B Arredondo Pérez, and S Islas Andrade, and M P Stern
April 1998, Revista clinica espanola,
C González Villalpando, and M E González Villalpando, and S Martínez Díaz, and D Rivera Martínez, and B Arredondo Pérez, and S Islas Andrade, and M P Stern
January 2008, [Zhonghua yan ke za zhi] Chinese journal of ophthalmology,
C González Villalpando, and M E González Villalpando, and S Martínez Díaz, and D Rivera Martínez, and B Arredondo Pérez, and S Islas Andrade, and M P Stern
July 2018, Journal of diabetes investigation,
C González Villalpando, and M E González Villalpando, and S Martínez Díaz, and D Rivera Martínez, and B Arredondo Pérez, and S Islas Andrade, and M P Stern
August 2000, Acta ophthalmologica Scandinavica,
C González Villalpando, and M E González Villalpando, and S Martínez Díaz, and D Rivera Martínez, and B Arredondo Pérez, and S Islas Andrade, and M P Stern
January 2021, Frontiers in endocrinology,
C González Villalpando, and M E González Villalpando, and S Martínez Díaz, and D Rivera Martínez, and B Arredondo Pérez, and S Islas Andrade, and M P Stern
December 2020, Zhonghua yi xue za zhi,
Copied contents to your clipboard!